Abstract:Introduction Despite its apparent efficacy in the treatment of a range of psychiatric disorders, electroconvulsive therapy (ECT) is viewed by some as a contentious treatment. Although most clinicians and researchers consider ECT a safe and effective treatment, there are ongoing and significantly publicised concerns about potential side effects. Objectives To explore use of ECT across Scotland in a large naturalistic clinical sample across an 11-year period from 2009 to 2019. To consider the efficacy and side effects of ECT for a range of common psychiatric disorders including, depression, bipolar depression, schizophrenia, and mania. Methods Using data from the Scottish Electroconvulsive Therapy (ECT) Accreditation Network (SEAN), information was collected for all adults who had received ECT. Variables included age, sex, Scottish Index of Multiple Deprivation (SIMD) quintile, International Classification of Diseases, Tenth Edition (ICD-10) diagnosis, indication for ECT, Mental Health Act status, consent status, entry and exit Montgomery-Asberg Depression Rating Scores (MADRS), entry and exit Clinical Global Index Severity CGI-S) scores and reported side effects. Side effects were recorded as present if the side effect was reported at any point during the episode of treatment. Results 4826 ECT episodes were recorded. The majority of episodes were in women (68.4%, n=3,301). Average age at treatment onset was 58.52 years. Males were slightly younger (m=58.24 years vs f= 58.65 years, p= 0.20). Mean number of treatments/episode was 9.59 (95% CI 9.32 – 9.85). Mean treatment dose delivered was 277.75mC (95%CI 272.88 – 282.63mC). 2920 episodes of treatment had CGI-S entry and exit recorded. At entry, mean CGI-S indicated marked illness (5.03 95% CI 4.99-5.07). Recipients with schizophrenia had the highest CGI-S score (5.45 95% CI 5.21-5.60), followed by those with post-partum disorders (5.38, 95% CI 4.61-6.14). At exit, mean CGI scores indicated borderline illness (2.07, 95% CI 2.03-2.11), recipients diagnosed with mixed affective state had the lowest CGI-S score (1.72, 95% CI 0.99-2.47) followed by those with schizoaffective disorder (2.01, 95% CI 1.76-2.42). Anaesthetic complications (n=34) and prolonged seizures (n=38) were rare, occurring in <1% of treatment episodes. Cardiovascular complications were reported in 2.2% (n= 102). Nausea was reported in 7.2% (n= 334) and muscle aches in 12% (n=560). Confusion was reported in 19% (n=879) and cognitive side effects were reported in 26.2% (n=1212). One third of treatment episodes reported confusion or cognitive side effects (33.1%, n=1545). Conclusions From this large naturalistic clinical sample, ECT appears to be effective in improving illness severity as measured by CGI-S score. While some side effects (such as prolonged seizures and cardiovascular complications) were rare, others (such as confusion or cognitive side effects) were relatively common. Disclosure of Interest None Declared

Electroconvulsive Therapy in Schizophrenia in China: A National Survey

Use of electroconvulsive therapy for Asian patients with schizophrenia (2001-2009): Trends and correlates.

Factors Associated with Utilization of Electroconvulsive Therapy During Psychiatric Hospitalization among Children and Adolescents in China.

Adjunctive Antidepressant Use In Schizophrenia In China: A National Survey (2002-2012)

Knowledge and attitudes of adolescents with psychiatric disorders and their caregivers towards electroconvulsive therapy in China

Comparison of treatment patterns in schizophrenia between China and Japan (2001-2009).

Effectiveness of Electroacupuncture and Electroconvulsive Therapy As Additional Treatment in Hospitalized Patients with Schizophrenia: A Retrospective Controlled Study

Accessibility, standards and challenges of electroconvulsive therapy in Western industrialized countries: A German example

Electroconvulsive therapy in a tertiary Australian mental health facility between 2009 and 2020

Antipsychotic Medications in Major Depression and the Association with Treatment Satisfaction and Quality of Life: Findings of Three National Surveys on Use of Psychotropics in China Between 2002 and 2012

Electroconvulsive therapy is associated with lower readmission rates in patients with schizophrenia

Electroconvulsive therapy for adolescents with severe depressive episode and suicidality: retrospective comparison between responders and non-responders

Electroconvulsive Therapy in the United States

Electroconvulsive Therapy for Obsessive-Compulsive Disorder: A Retrospective Study

Electroconvulsive Therapy Efficacy in Adolescents with Mental Illness: A Retrospective Comparison

Electroconvulsive therapy use in New South Wales between 1944 and 1949

Progressive Changes in Brain Regional Homogeneity Induced by Electroconvulsive Therapy among Patients with Schizophrenia

Electroconvulsive Therapy (ECT): A Scotland Wide Naturalistic Study of 4,826 treatment episodes

Clinical effect of modified electroconvulsive therapy on schizophrenia

An Investigation of the Characteristics of Outpatients with Epilepsy and Antiepileptic Drug Utilization in a Multicenter Cross-Sectional Study in China

Efficacy and Safety of Treating Patients with Refractory Schizophrenia with Antipsychotic Medication and Adjunctive Electroconvulsive Therapy: a Systematic Review and Meta-Analysis.